gamma-glutamyl-leucine has been researched along with Cancer of Esophagus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, W; Ke, Y; Sun, Y; Wang, K; Wang, N; Wang, X; Wei, B; Xu, X; Yan, H; Zhang, J; Zhou, Y | 1 |
1 other study(ies) available for gamma-glutamyl-leucine and Cancer of Esophagus
| Article | Year |
|---|---|
Oridonin induces ferroptosis by inhibiting gamma-glutamyl cycle in TE1 cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chromatography, Liquid; Cysteine; Dipeptides; Diterpenes, Kaurane; Esophageal Neoplasms; Ferroptosis; gamma-Glutamyltransferase; Glutamate-Cysteine Ligase; Glutamates; Glutathione; Humans; Iron; Malondialdehyde; Metabolome; Phospholipid Hydroperoxide Glutathione Peroxidase; Reactive Oxygen Species; Tandem Mass Spectrometry | 2021 |